Olayode Babatunde

Olayode Babatunde is an Assistant Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), specializing in Hematology-Oncology with a clinical and research focus on sarcoma. His work centers on advancing immunotherapy applications for sarcoma subtypes through molecular characterization and biomarker discovery.

Dr. Babatunde's research spans sarcoma oncology, tumor immunology, and precision medicine approaches. He investigates immune checkpoint blockade mechanisms in fusion-positive sarcomas and leiomyosarcoma, characterizes genetic drivers like TP53 mutations, and explores correlates of treatment response. His work bridges molecular diagnostics with clinical therapeutic strategies to improve outcomes for sarcoma patients.

Analysis of his recent publications reveals a cohesive research trajectory focused on overcoming immunotherapy resistance in sarcomas. His studies integrate molecular subtyping (CIC::DUX4 fusions, TP53 status) with immune microenvironment analysis to identify predictive biomarkers and optimize checkpoint blockade strategies across diverse sarcoma histologies.

At MSK, Dr. Babatunde operates within the Solid Tumor Oncology Division and Department of Medicine, collaborating with multidisciplinary teams including the Hematology-Oncology service. His research leverages MSK's sarcoma clinical trials infrastructure and translational research resources to drive innovation in sarcoma therapeutics.